Boule Diagnostics AB (publ) (BOUL.ST)
SEK 8.21
(-1.7%)
SEK 8.21
(-1.7%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 62.4 Million SEK | -17.09% |
| 2022 | 75.26 Million SEK | 27.49% |
| 2021 | 59.03 Million SEK | 8.24% |
| 2020 | 54.54 Million SEK | -5.29% |
| 2019 | 57.59 Million SEK | -0.75% |
| 2018 | 58.02 Million SEK | 14.32% |
| 2017 | 50.75 Million SEK | -14.24% |
| 2016 | 59.18 Million SEK | 8.08% |
| 2015 | 54.76 Million SEK | 18.54% |
| 2014 | 46.19 Million SEK | -3.46% |
| 2013 | 47.85 Million SEK | 4.86% |
| 2012 | 45.63 Million SEK | 5.2% |
| 2011 | 43.37 Million SEK | 13.31% |
| 2010 | 38.28 Million SEK | 2.11% |
| 2009 | 37.49 Million SEK | -12.87% |
| 2008 | 43.02 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 68.2 Million SEK | 9.29% |
| 2024 Q3 | 59.5 Million SEK | -15.12% |
| 2024 Q2 | 70.1 Million SEK | 2.79% |
| 2023 Q2 | 83.4 Million SEK | 3.35% |
| 2023 FY | 62.4 Million SEK | -17.09% |
| 2023 Q4 | 62.4 Million SEK | -17.24% |
| 2023 Q3 | 75.4 Million SEK | -9.59% |
| 2023 Q1 | 80.7 Million SEK | 7.22% |
| 2022 Q3 | 76.7 Million SEK | 14.14% |
| 2022 Q1 | 69.4 Million SEK | 17.55% |
| 2022 Q4 | 75.26 Million SEK | -1.87% |
| 2022 FY | 75.26 Million SEK | 27.49% |
| 2022 Q2 | 67.2 Million SEK | -3.17% |
| 2021 Q4 | 59.03 Million SEK | 1.97% |
| 2021 FY | 59.03 Million SEK | 8.24% |
| 2021 Q1 | 51.1 Million SEK | -6.31% |
| 2021 Q3 | 57.9 Million SEK | -1.7% |
| 2021 Q2 | 58.9 Million SEK | 15.26% |
| 2020 Q3 | 55.7 Million SEK | -19.97% |
| 2020 FY | 54.54 Million SEK | -5.29% |
| 2020 Q1 | 65.2 Million SEK | 13.21% |
| 2020 Q2 | 69.6 Million SEK | 6.75% |
| 2020 Q4 | 54.54 Million SEK | -2.08% |
| 2019 Q3 | 61.3 Million SEK | 4.61% |
| 2019 FY | 57.59 Million SEK | -0.75% |
| 2019 Q1 | 62.1 Million SEK | 7.02% |
| 2019 Q2 | 58.6 Million SEK | -5.64% |
| 2019 Q4 | 57.59 Million SEK | -6.05% |
| 2018 Q2 | 53.9 Million SEK | 16.16% |
| 2018 Q4 | 58.02 Million SEK | 10.11% |
| 2018 FY | 58.02 Million SEK | 14.32% |
| 2018 Q1 | 46.4 Million SEK | -8.59% |
| 2018 Q3 | 52.7 Million SEK | -2.23% |
| 2017 Q1 | 63.8 Million SEK | 7.8% |
| 2017 Q4 | 50.75 Million SEK | 1.93% |
| 2017 Q3 | 49.8 Million SEK | -9.78% |
| 2017 Q2 | 55.2 Million SEK | -13.48% |
| 2017 FY | 50.75 Million SEK | -14.24% |
| 2016 Q2 | 52.2 Million SEK | 9.89% |
| 2016 FY | 59.18 Million SEK | 8.08% |
| 2016 Q4 | 59.18 Million SEK | 10.42% |
| 2016 Q3 | 53.6 Million SEK | 2.68% |
| 2016 Q1 | 47.5 Million SEK | -13.26% |
| 2015 Q2 | 54.6 Million SEK | 12.81% |
| 2015 Q4 | 54.76 Million SEK | -6.39% |
| 2015 Q3 | 58.5 Million SEK | 7.14% |
| 2015 Q1 | 48.4 Million SEK | 4.77% |
| 2015 FY | 54.76 Million SEK | 18.54% |
| 2014 FY | 46.19 Million SEK | -3.46% |
| 2014 Q2 | 47.2 Million SEK | 2.39% |
| 2014 Q4 | 46.19 Million SEK | -4.75% |
| 2014 Q3 | 48.5 Million SEK | 2.75% |
| 2014 Q1 | 46.1 Million SEK | -3.67% |
| 2013 Q2 | 52.06 Million SEK | 6.84% |
| 2013 Q1 | 48.72 Million SEK | 6.77% |
| 2013 FY | 47.85 Million SEK | 4.86% |
| 2013 Q4 | 47.85 Million SEK | -8.22% |
| 2013 Q3 | 52.13 Million SEK | 0.15% |
| 2012 Q2 | 45.56 Million SEK | -0.32% |
| 2012 Q3 | 46.07 Million SEK | 1.14% |
| 2012 Q4 | 45.63 Million SEK | -0.96% |
| 2012 FY | 45.63 Million SEK | 5.2% |
| 2012 Q1 | 45.7 Million SEK | 5.37% |
| 2011 Q1 | 38.65 Million SEK | 0.97% |
| 2011 Q4 | 43.37 Million SEK | -2.01% |
| 2011 Q3 | 44.26 Million SEK | 10.63% |
| 2011 Q2 | 40.01 Million SEK | 3.51% |
| 2011 FY | 43.37 Million SEK | 13.31% |
| 2010 Q4 | 38.28 Million SEK | 0.0% |
| 2010 FY | 38.28 Million SEK | 2.11% |
| 2009 FY | 37.49 Million SEK | -12.87% |
| 2008 FY | 43.02 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -812.414% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 48.515% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 48.515% |
| Arcoma AB | 28.02 Million SEK | -122.642% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | -110.484% |
| BICO Group AB (publ) | 493.1 Million SEK | 87.345% |
| CellaVision AB (publ) | 126.03 Million SEK | 50.491% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -920.442% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -3423.59% |
| C-Rad AB (publ) | 64.09 Million SEK | 2.652% |
| Duearity AB (publ) | 4.15 Million SEK | -1400.361% |
| Dignitana AB (publ) | 7.41 Million SEK | -741.764% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -1586.486% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.027% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 3806.848% |
| Iconovo AB (publ) | -4.86 Million SEK | 1383.422% |
| Integrum AB (publ) | 22.36 Million SEK | -179.045% |
| Luxbright AB (publ) | 8000.00 SEK | -779900.0% |
| Mentice AB (publ) | 14.1 Million SEK | -342.428% |
| OssDsign AB (publ) | 4.3 Million SEK | -1349.814% |
| Paxman AB (publ) | 19.99 Million SEK | -212.016% |
| Promimic AB (publ) | 330 Thousand SEK | -18809.091% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -755.732% |
| SciBase Holding AB (publ) | 11.91 Million SEK | -423.534% |
| ScandiDos AB (publ) | 22.69 Million SEK | -175.011% |
| Sectra AB (publ) | 36.59 Million SEK | -70.538% |
| Sedana Medical AB (publ) | 42.97 Million SEK | -45.201% |
| Senzime AB (publ) | 20.34 Million SEK | -206.785% |
| SpectraCure AB (publ) | 1.00 SEK | -6239999900.0% |
| Stille AB | 66.55 Million SEK | 6.24% |
| Vitrolife AB (publ) | 413 Million SEK | 84.891% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 55.933% |